Title Why down-scheduling medicines is fraught with danger Degree of recognition National Media name/outlet News GP Media type Web Duration/Length/Size 3 pages Country/Territory Australia Date 12/04/19 Description The Government has recently directed the Therapeutic Goods Administration (TGA) to propose a new schedule for more medicines to be available over the counter.
While the move is ostensibly to improve access to these medicines, I – and many others – have serious questions.
The effect has been that the TGA has created a new group between Schedule 4 (prescription-only) and Schedule 3 (pharmacy-only) drugs, labelled Schedule 3 Appendix M (Schedule 3M). In effect, this is Schedule 3½.
This article describes some of the risks and unintended consequences for this move.
Producer/Author Dr Mark Morgan on behalf of RACGP Media Persons Mark Morgan